Launch week offerEnds in00h00m00s

annual Promonthly Pro

Carlo Genova

Assistant Professor

University of Genoa

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (16)

Paolo Borghetti

Brescia University College

ITALY

View details

Marco Tagliamento

Researcher/Assistant Professor

University of Genoa

ITALY

View details

Jarushka Naidoo

Honorary Senior Lecturer

Royal College of Surgeons in Ireland

IRELAND

View details

Andrea Riccardo Filippi

Associate Professor

University of Milan

ITALY

View details

Arianna Marinello

Institut Gustave Roussy

FRANCE

View details

Lucia Del Mastro

dirigente medico

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro

ITALY

View details

Italo F Angelillo

Professore Ordinario

Università degli Studi della Campania Luigi Vanvitelli Scuola di Medicina e Chirurgia

ITALY

View details

Fabian Acker

University Hospital Frankfurt

GERMANY

View details

Mingjia Li

Assistant Professor

Ohio State University

UNITED STATES

View details

Barletta Giulia

Ricercatore sanitario; MD

Ospedale Policlinico San Martino

ITALY

View details

Silvia NOVELLO

Professor

Università degli Studi di Torino

ITALY

View details

Giovanni Farinea

University of Turin

ITALY

View details

Andrea De Giglio

University of Bologna

ITALY

View details

Fabrizio Stracci

Associate Professor

University of Perugia

ITALY

View details

Francesca Larese Filon

Full professor

Università degli Studi di Torino

ITALY

View details

Lorenzo Antonuzzo

University of Florence

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carlo Genova

Research Interests

Make your next move.

Explore related searches

Articles (20)

Osimertinib in advanced non-small cell lung cancer (NSCLC) harboring different EGFR uncommon variants: real-world data from the Italian biomarker ATLAS database

APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer

Braf-mutant metastatic non–small-cell lung cancer: Real world data from the Italian biomarker atlas database

Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to KRAS status: An Italian real-world study

Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study

Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trial

Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEX

Targeted therapies in non-small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of management

Response to Letter Re: Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the ISTOP study

Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study

A blood-based immune-suppressive index stratifies immunotherapy outcomes in advanced NSCLC

Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥ 50%: real-world data from the Italian ATLAS registry

Amivantamab in advanced non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real-world data from the Italian ATLAS Registry

Hunting for signal in the noise: identifying robust CT radiomic features across variable scanning settings

Modelled effect on mesothelioma mortality of the asbestos ban in Italy and the subsequent phases of exposure

Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the I-STOP study

Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study

Pericardial Mesothelioma: Diagnostic and Therapeutic Management, a Population-Based Study in Italy

Diagnostic and Therapeutic Management of Mesothelioma of the Tunica Vaginalis Testis: A Population-Based Study in Italy

Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity

Collaborators (16)

Paolo Borghetti

Marco Tagliamento

Jarushka Naidoo

Andrea Riccardo Filippi

Arianna Marinello

Lucia Del Mastro

Italo F Angelillo

Fabian Acker

Mingjia Li

Barletta Giulia

Silvia NOVELLO

Giovanni Farinea

Andrea De Giglio

Fabrizio Stracci

Francesca Larese Filon

Lorenzo Antonuzzo

Make your next move.